|
Abnova is invited to speak at 8th World IVD Summit 2017 in Nanjing, China Dates: 22-24 February, 2017 Invited Speaker: Wilber Huang, MD Presentation Date: Friday, 24 February, 2017 at 11:00 AM Presentation Topic: Applications of Circulating Tumor Cell Detection in Clinical Oncology |
+886-2-87511888
sales@abnova.com
Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)